POCI · Precision Optics Corporation, Inc. · Metrics
Market Cap
$47.61M
Shares
10.94M
POCI metrics
68 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$4.39
Market cap
$47.61M
Price action
20 metricsPrice change (1W)
-2.2%
Price change (30D)
+2.6%
Price change (3M)
-23.0%
Price change (6M)
-1.4%
Price change (YTD)
+3.8%
Price change (1Y)
-2.2%
Trailing year
Price change (5Y)
—
52-week high
$5.96
52-week low
$3.90
Change from 52-week high
-27.0%
Change from 52-week low
+11.5%
Annualized volatility
49.9%
Annualized volatility (3M)
40.6%
Beta
0.4
RSI (14D)
48.1
Price vs SMA 50
-2.4%
Price vs SMA 200
-5.4%
Avg volume (3M)
38,341
Relative volume
0.4
Average dollar volume
$177,506
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
10.94M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.3×
reciprocal yield 75.4%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.6×
reciprocal yield 60.8%
P / book
2.4
reciprocal yield 42.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-10.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.8×
reciprocal yield 55.5%
EV / revenue historical average (5Y)
1.9×
reciprocal yield 51.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-05-13
Profitability
9 metricsGross margin
13.8%
Operating margin
-16.4%
Trailing 12 months
Net margin
-17.0%
Gross profit (TTM)
$4.01M
Operating profit (TTM)
−$4.76M
Net income (TTM)
−$4.93M
Trailing 12 months
Diluted EPS (TTM)
$-0.64
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+108.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$28.94M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+12.7%
Year over year · more shares
Revenue CAGR (3Y)
+6.8%
Revenue CAGR (5Y)
+14.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-24.5%
Return on assets
-14.6%
Debt / equity
0.1
Current ratio
2.1
EBITDA (TTM)
−$4.49M
Free cash flow (TTM)
—
Quick ratio
1.7
Interest coverage
-29.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$9.25M
Latest balance sheet
Cash & equivalents
$10.68M
Total assets
$33.69M
Total debt
$1.43M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$1.47M
Capital expenditures (TTM)
$227,209
R&D (TTM)
$1.06M
SG&A (TTM)
$7.71M
Stock compensation (TTM)
$1.18M
R&D / revenue
3.7%
Stock compensation / revenue
4.1%
Ownership (13F)
3 metrics13F filers
31
13F filer change QoQ
+5
Institutional ownership
33.4%
Short interest
3 metricsShort interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
21 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
867840
CUSIP
740294400
13F (30d)
20 filings
20 filers
Visit website
Investor relations